Arrowhead Pharmaceuticals Inc (ARWR)
US$ 15.289.38%
Price Chart
Key Statistics
Market Cap
$ 2.06B
P/E Ratio
0.00
Revenue (TTM)
$ 545.21M
Volume
4.42M
52W High
$ 30.41
52W Low
$ 9.57
Dividend Yield
0.00%
Beta
0.90
Technicals
50-Day MA
13.7114
200-Day MA
19.2833
52 Week High
30.41
52 Week Low
9.57
About ARWR
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States.
Employees
609
Headquarters
Pasadena, CA
CEO
Dr. Christopher R. Anzalone Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg